CXCL9 and hepatocellular carcinoma: We validated the widespread presence of CXCL9/SPP1 in bulk data across multiple cohorts, proving that the CXCL9/SPP1 ratio may serve as a biomarker reflecting the state of the micro-environment and different prognostic outcomes in HCC patients.